Disease-Modifying Antirheumatic Drug (DMARD) Market, By Drug Type (Synthetic (sDMARD) (Conventional synthetic (csDMARDs) (Methotrexate, Sulfasalazine, Leflunomide, Hydroxychloroquine, Gold Salts)), Targeted synthetic DMARDs (tsDMARDs), Biological DMARDs (bDMARD) (Original DMARDs (boDMARDs), Biosimilar DMARDs (bsDMARDs) (Primary, Secondary, Tertiary)), Others), By Route of Administration (Oral, Parenteral, Others), By Indication (Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, Systemic Lupus Erythematosus, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)